SPONSOR
University of Michigan Rogel Cancer Center
Total Trials
6
Recruiting
6
Phases
Phase 2, Phase 1
Conditions studied: Oropharyngeal CancerSquamous Cell Carcinoma of the OropharynxLocally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckRecurrent Cutaneous Squamous Cell Carcinoma of the Head and NeckStage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Prostate CancerMetastatic Castration-Resistant Prostate CarcinomaColonic NeoplasmsRecurrent Diffuse Hemispheric Glioma, H3 G34-MutantRecurrent Malignant Brain Neoplasm
NCT05894083 Phase 2
Recruiting
A Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan (CuSToMIze)
Oropharyngeal Cancer
NCT06580054 Phase 2
Recruiting
Pembrolizumab for the Treatment of Locally Advanced and/or Recurrent Orbital or Periocular Cutaneous Squamous Cell Carcinoma
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck
NCT04396808
Recruiting
Genomics in Michigan to AdJust Outcomes in Prostate canceR (G-MAJOR) for Men With Newly Diagnosed Favorable Risk Prostate Cancer
Prostate Cancer
NCT07096999
Recruiting
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
Metastatic Castration-Resistant Prostate Carcinoma
NCT00843375
Recruiting
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
Colonic Neoplasms
NCT06914479 Phase 1
Recruiting
Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors
Recurrent Diffuse Hemispheric Glioma, H3 G34-Mutant